Related Experiment Video
Updated: Mar 16, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary Hypertension
Peter Oishi1, Jeffrey R Fineman
1Both authors: Division of Critical Care Medicine, Department of Pediatrics, University of California San Francisco School of Medicine, University of California San Francisco Benioff Children's Hospital, San Francisco, CA.
Insights
Pediatric pulmonary hypertension, often linked to congenital heart disease, poses significant risks. Right ventricular failure is the primary cause of mortality in these critically ill children.
Area of Science:
- Pediatric Cardiology
- Pulmonology
- Critical Care Medicine
Background:
- Pulmonary hypertension in children, particularly when associated with congenital heart disease, represents a critical clinical challenge.
- Congenital cardiac defects can lead to abnormal pulmonary blood flow or venous drainage, causing vascular changes.
- Right ventricular dysfunction is a key factor in the progression and severity of pediatric pulmonary hypertension.
Purpose of the Study:
- To comprehensively review the clinical classification and diagnosis of pediatric pulmonary hypertension.
- To elucidate the pathophysiology, emphasizing right ventricular function and ventricular interaction.
- To outline current management strategies and therapeutic options for this high-risk population.
Main Methods:
- Literature search of MEDLINE and PubMed databases.
- Review focused on clinical classification, diagnosis, pathophysiology, and management.
- Emphasis on the role of congenital heart disease and right ventricular function.
Main Results:
- Children with pulmonary hypertension and congenital heart disease are a high-risk group.
- Increased pulmonary blood flow or impaired venous drainage from cardiac defects initiates vascular pathology.
- Right ventricular failure is the most direct cause of mortality.
Conclusions:
- Pulmonary hypertension in children with congenital heart disease requires specialized management.
- Understanding the interplay between cardiac defects, pulmonary vasculature, and right ventricular function is crucial.
- Effective management strategies are essential to reduce mortality, primarily linked to right ventricular failure.
Objectives:
To review the clinical classification, diagnosis, and pathophysiology of pulmonary hypertension in children, emphasizing the role of right ventricular function, ventricular interaction, and congenital heart disease in the evolution and progression of disease, as well as management strategies and therapeutic options.
Data Source:
MEDLINE, PubMed.
Conclusions:
Critically ill children with pulmonary hypertension associated with congenital heart disease are a high-risk population. Congenital cardiac defects resulting in either increased pulmonary blood flow or impaired pulmonary venous drainage predispose patients to developing structural and functional aberrations of the pulmonary vasculature. Mortality from pulmonary hypertension is most directly related to right ventricular failure.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Embolism I: Introduction
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...

